Study finds endocrine-disrupting chemicals in menstrual products sold in South Africa

A new study by the University of the Free State has found that sanitary pads and pantyliners sold in South Africa contain endocrine-disrupting chemicals, including in products marketed as free from harmful substances. The research, published in the journal Science of the Total Environment, analysed 16 brands of sanitary pads and eight types of pantyliners…

Read Full News
HIV Drug

South Africa’s R15.5bn HIV Drug Tender Faces Scrutiny Over ‘Local Manufacturing’ Claims

South Africa’s R15.5 billion antiretroviral (ARV) procurement programme, which supplies treatment to roughly eight million people, is under parliamentary scrutiny after officials conceded they have not verified whether the majority of medicines are genuinely produced locally. The Department of Health has long maintained that at least 70% of ARVs under the national tender are sourced…

Read Full News

Child-like sex dolls trigger concerns: EU launches a probe into Shein

Brussels has launched a formal probe into fast-fashion giant Shein over suspected breaches of the European Union’s digital platform rules, including allegations that illegal items were sold through its marketplace. The European Commission confirmed that the Singapore-headquartered retailer is under investigation under the bloc’s Digital Services Act (DSA). The inquiry will examine concerns about the…

Read Full News

Patent barriers and high costs limit reach of booming weight-loss drug market in South Africa

Sales of glucagon-like peptide-1 (GLP-1) receptor agonists have climbed sharply in South Africa’s private healthcare sector, yet the majority of potential beneficiaries remain excluded due to prohibitive pricing and restricted medical scheme coverage. Neither the public health system nor most private insurers fully fund these treatments for obesity, despite recent clinical guidelines endorsing their use….

Read Full News